UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Target date funds adjust asset allocations over time toward a chosen retirement year, simplifying diversification and rebalancing for many savers.
19,808 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
SpaceX plans a June NASDAQ debut with a tight float and a 366-day lock-up for founders. Analysts warn index funds cou...
Investors often wonder if Nvidia stock should be bought before major AI events. This article breaks down historical p...
Mega IPOs attract huge attention, but history teaches a sober lesson about valuation, timing, and long-term returns. ...
Fastly stock already doubled this year, leaving many investors wondering if the rally can continue. This guide breaks...
When a metropolitan bank director sells shares, it catches the eye of investors. This article explains insider filing...
Cryptio has closed a $45 million Series B to scale its enterprise crypto accounting platform, aiming to help large fi...
A South Florida case tied to $34 million in COVID relief funds led the FBI to offer up to $150,000 for information. T...
When a top executive sells stock, the market takes notice. This deeper look at Bristow Group's just sold helps you se...
Illinois embeds a first-of-its-kind 0.2% tax on digital asset activity in its $55.9 billion budget, set to take effec...
When a senior leader at Black Stone Minerals sells a sizeable block of units, it can ripple through the stock. This a...
As Fed policy shifts and market volatility persists, analysts say the era of an automatic market backstop is fading. ...